Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor.
about
Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody.Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody.Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guérin.Biomarkers for precision medicine in bladder cancer.Bladder cancer cells induce immunosuppression of T cells by supporting PD-L1 expression in tumour macrophages partially through interleukin 10.Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer
P2860
Q33591239-7CF526BE-F0E0-4AF8-B8CB-E1B17E1DBA79Q37658381-1EB6D13B-D3BB-4377-8EBC-0692DCBFF7CAQ38855950-AC562F7B-DDE8-4B22-BA4D-CA06DCCDB5F1Q39005578-06FAC067-5725-424B-A986-FAC6AF2444B7Q39023158-4982D77A-E900-4115-98A5-86474FE4E255Q51005809-33E7B469-77E7-489F-9360-15C122F42319Q58705140-2780CF50-3EFB-4B07-A81D-234159F2E0DB
P2860
Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Systemic Immunotherapy of Non- ...... 1 Immune Checkpoint Inhibitor.
@en
type
label
Systemic Immunotherapy of Non- ...... 1 Immune Checkpoint Inhibitor.
@en
prefLabel
Systemic Immunotherapy of Non- ...... 1 Immune Checkpoint Inhibitor.
@en
P2093
P2860
P1476
Systemic Immunotherapy of Non- ...... 1 Immune Checkpoint Inhibitor.
@en
P2093
Amanda J Vandeveer
Helen Sabzevari
Jeffrey Schlom
John W Greiner
Jonathan K Fallon
Robert Tighe
P2860
P304
P356
10.1158/2326-6066.CIR-15-0176
P577
2016-02-26T00:00:00Z